At NeoTargets, we utilize our AI-powered proprietary in silico tool to identify selective and highly druggable cancer targets and use our oncotarget discovery platform to generate optimal drug targets with proven potency and safety. Our approach de-risks drug development and shortening timelines, reducing costs, and significantly increasing success rates, leading to faster time to market, greater market share, and extended patent protection.
We have identified various cancer-specific targets with optimal characteristics across 140 cancer subtypes using our proprietary tools. These targets are validated in translational cell models to eliminate harmful candidates early and are further tested in well characterized patient samples, cancer-driving cells, and animal models. This rigorous process delivers curative potential targets for effective, targeted treatments.
NeoTargets has an in-house pipeline of early-stage drug development projects for multiple myeloma and glioblastoma. Additionally, we are collaborating with Sprint Bioscience to develop a treatment for acute myeloid leukemia.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Stockholm, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://neotargets.com/
- Keywords
- Stockholm.
- HQ
- Stockholm
- Competitors
- Zyneyro, Kripthonite Therapeutics, Coastal Hazards, Equity, Economic Prosperity, and Resilience (CHEER) Hub, BioReperia, Marigold Investment Management, Centrum Materiałów Polimerowych i Węglowych Polskiej Akademii Nauk, Stiftelsen för strategisk forskning, SSF, Zenit Science, Sprint Bioscience, Quantum Theory Center.
Neotargets Ab Questions
Neotargets Ab's website is https://neotargets.com/
Neotargets Ab's LinkedIn profile is https://se.linkedin.com/company/neotargets
Neotargets Ab has
2 employees.
View email and phone details for 2
employees at Neotargets Ab.
Neotargets Ab's industry is
Biotechnology Research
Neotargets Ab's top competitors are
Zyneyro,
Kripthonite Therapeutics,
Coastal Hazards, Equity, Economic Prosperity, And Resilience (Cheer) Hub,
Bioreperia,
Marigold Investment Management,
Centrum Materiałów Polimerowych I Węglowych Polskiej Akademii Nauk,
Stiftelsen För Strategisk Forskning, Ssf,
Zenit Science,
Sprint Bioscience,
Quantum Theory Center.
Neotargets Ab's categories are Biotechnology Research
Neotargets Ab's founding year is 2022
